Furanocoumarins in anticancer therapy - For and against

Copyright © 2020 Elsevier B.V. All rights reserved..

Furanocoumarins are a class of natural compounds produced by several plants, including those consumed by humans. They have been used medicinally in eastern countries for ages. Given the growing body of evidence about their anticancer potential and observations that naturally occurring compounds potentiate the antitumor activity of chemotherapeutics, more attention is paid to elucidation of the nature of furanocoumarins and the possibility of using thereof in practice. The general mechanism by which furanocoumarins eliminate cancer cells is based on cell cycle blockage and initiation of programmed death like apoptosis or autophagy. The precise molecular mechanism of such an action depends on the chemical structure of furanocoumarins, which is based on the furan ring attached to the coumarin backbone in a linear or angular form as well as the type, location, and number of the substituents attached. The review summarizes the current evidence of the antitumor properties of linear and angular furanocoumarins with special emphasis on the molecular mechanism of elimination of cancer cells via apoptosis and autophagy. Negative aspects of the use of coumarins in anticancer therapy will be also discussed especially in the context of their phototoxicity and potential cancerogenic effect.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:142

Enthalten in:

Fitoterapia - 142(2020) vom: 01. Apr., Seite 104492

Sprache:

Englisch

Beteiligte Personen:

Sumorek-Wiadro, Joanna [VerfasserIn]
Zając, Adrian [VerfasserIn]
Maciejczyk, Aleksandra [VerfasserIn]
Jakubowicz-Gil, Joanna [VerfasserIn]

Links:

Volltext

Themen:

Angelicin
Antineoplastic Agents, Phytogenic
Cancer
Furanocoumarins
Furocoumarins
Journal Article
Programmed cell death
Psoralen
Review

Anmerkungen:

Date Completed 08.12.2020

Date Revised 14.12.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.fitote.2020.104492

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306272261